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ABSTRACT
Endoscopic endonasal skull base surgery has emerged as the treatment modality of choice for a range of
skull base lesions, particularly pituitary adenomas. However, navigation and manipulation of the nasal cor-
ridor and paranasal sinuses requires that surgeons are aware of effective techniques to maximize patient
outcomes and avoid sinonasal morbidity postoperatively. This paper is a narrative review aimed to provide
an updated and consolidated report on the perioperative management of the nasal corridor and paranasal
sinuses in the setting of endoscopic skull base surgery for pituitary disease. Anatomic variants and
common surgical techniques are discussed. Post-operative complications are evaluated in detail.
Understanding the structural implications of the endonasal approach to the sphenoid is crucial to opti-
mization of the surgical outcomes. We propose guidelines for perioperative management of endoscopic
endonasal skull base surgery for pituitary diseases. Standardized treatment algorithms can improve patient
satisfaction, and increase the comparability and the quality of reported information across
research studies.
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Introduction
By demonstrating comparable outcomes to traditional surgical
approaches, endonasal approaches to pituitary tumors have
become a dominant method of treatment.1,2 Transsphenoidal sur-
gery is now commonly used in the management of sellar lesions,
including pituitary tumors, Rathke’s cleft cysts, and craniophar-
yngiomas.3 Microscopic visualization of the sphenoid for pituit-
ary disease management became the gold standard for endonasal
skull base surgery from the early 1900s, as it obviated the need
for brain retraction and complex transcranial interventions.4,5
The endoscopic revolution was seeded two decades ago; endo-
scopic transsphenoidal resection of pituitary tumors was intro-
duced by Jankowski et al. in 1992, popularized in the late 1990s
by Jho and Carrau,3,6 and continued by Kassam and colleagues
in the 2000s.7–10 Offering a wider panoramic view and superior
visualization of the suprasellar and lateral compartments, as well
as the cavernous sinus walls for safe microdissection, endoscopic
endonasal transsphendoidal surgery has gained wide acceptance
as a safe, minimally-invasive approach to pituitary diseases.11,12
In contrast to microscopic transsphenoidal surgery, which is
performed via a transseptal subperichondrial approach, endonasal
transsphenoidal surgery relies on dissection of the nasal cavity to
permit wider access and accommodate four-hand surgery. The
technique is commonly performed as a collaboration between
otolaryngologists and neurosurgeons and requires a thorough
comprehension of the endonasal corridor, anatomic variants and
disease pathology that may impact surgical planning. This review
is intended to provide an approach to management of the para-
nasal sinuses and endonasal passage to preserve sinonasal
function, reduce complications and optimize interdisciplinary
collaboration in endoscopic transsphenoidal approaches to
the sella.
Pre-operative considerations
Patient evaluation and optimization
A comprehensive history and physical examination to ensure the
nasal cavity and paranasal sinuses are optimized prior to surgery
is central to appropriate preparation.13 Previous sinus surgery
does not preclude endonasal skull base surgery but the nature
and extent of previous surgical resection should be carefully dis-
cussed and evaluated as this may influence reconstructive options
or compromise nasal structure.
Physical examination focuses on inspection of the nasal cavity
and posterior nasopharynx to visualize the septum, turbinates
and identify signs of sinonasal disease.14 Anterior rhinoscopy and
nasal endoscopy are essential to evaluate the inferior turbinate
and anterior nasal septum. It also permits identification of poten-
tial obstructions of the nasal corridor, including turbinate hyper-
trophy, nasal polyps, anatomic variants and inflammatory
disease. Identifying and addressing symptomatic pathology in the
endonasal corridor provides the opportunity to improve patient’s
quality of life with regard to nasal function, while treating the
primary skull base pathology.13
All patients should be screened for signs and symptoms of
rhinosinusitis, an established predictor of low post-operative
quality of life scores in endonasal skull base surgery.15
Rhinosinusitis refers to symptomatic inflammation of the nose
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and paranasal sinuses and can be subclassified based on the dur-
ation and etiology of disease.13,16 Paranasal sinus inflammation
can be precipitated by infection, allergies, immune dysfunction,
cilia disorder and structural abnormalities.13 Studies have demon-
strated favorable outcomes with concurrent management of sinus
and pituitary disease.17,18 Appropriate management of paranasal
sinuses, particularly acute, chronic and fungal rhinosinusitis, has
been recommended to ensure healthy sinonasal function in
patients undergoing endoscopic skull base surgery.17 Acute rhi-
nosinusitis, defined by the American Academy of Otolaryngology
as rhinosinusitis of less than four weeks duration, or fungal para-
nasal sinus disease require staged management of active sinus
disease before proceeding with endonasal skull base surgery.16,17
Treatment regimens for acute rhinosinusitis include watchful
waiting with close follow-up, the use of nasal irrigations, culture-
directed antibiotics, decongestants, intranasal corticosteroids, and
oral steroids to eradicate infection and stabilize inflamma-
tion.16,17,19 Fungal paranasal sinus disease, particularly allergic
fungal rhinosinusitis and fungal balls, requires endoscopic sinus
surgery to eradicate paranasal sinus disease.14 In contrast,
patients with mild or moderate chronic rhinosinusitis (>12
weeks duration) with or without nasal polyposis that is refractory
to maximal medical management (including culture-directed
antibiotics, nasal irrigations, allergy therapy, oral steroids and
decongestants) may be surgically addressed at the time of skull-
base surgery without risk of developing an intracranial
infection.17,20,21
There is limited evidence in the literature on the use of peri-
operative steroids in the setting of endoscopic skull base surgery
for concurrent pituitary disease and chronic paranasal sinus dis-
ease or nasal polyposis. Perioperative steroids for functional sinus
surgery in management of chronic rhinosinusitis with nasal pol-
yps and allergic fungal sinusitis has been found to improve surgi-
cal visualization, decrease operative time and delay polyp
recurrence in allergic fungal sinusitis.22 Given the favorable out-
comes observed in endoscopic sinus surgery, it is worthwhile to
consider incorporating perioperative steroids into the multimodal
treatment strategy for patients undergoing endoscopic skull base
surgery with chronic inflammatory sinus disease, but further
research is required to establish the clinical efficacy of steroids in
this setting.
Imaging studies
Pre-operative imaging, including magnetic resonance (MR)
imaging of the brain and computed tomography (CT) of the
head that includes the sinuses, is essential in surgical planning
of the primary skull base lesion and in delineating the bony
boundaries, symmetry and aeration of the sphenoid sinus in
relation to the sphenoid sinus septum, sella floor and carotid
canals.3,23 CT is the current imaging standard for the evaluation
of inflammatory diseases of the paranasal sinuses (Figure 1).13
Neuroimaging will also serve to guide surgical navigation and
planning through complex sinus passages and skull base
pathology.14
In the endoscopic era, a higher premium is placed on scru-
tinizing the nasal and sinus anatomy than in conventional
microscopic approaches. Anatomic variants commonly encoun-
tered in the transsphenoidal approach include anomalies of the
nasal septum and turbinates.24 Concha bullosa, an aeration of
the middle turbinate,14 often correlates with patients with
highly pneumatized ethmoid sinuses (Figure 2).25 A paradox-
ical middle turbinate refers to the abnormal curvature of the
middle turbinate laterally adjacent to the nasal septum, as
opposed to its standard medial curvature.14,25 Nasal septal
deviation defines an asymmetric bowing of the nasal septum
that may narrow the nasal corridor and may narrow one nare
significantly.14 Large studies of septal abnormalities have con-
cluded that non-deviated septums are only present in 7.5–23%
of individuals, indicating a high prevalence of septal deviations
in the general population.25 These abnormalities, particularly
deviations of the caudal septum and bone spurs, may need to
be addressed before surgeons can gain access to the nasal cor-
ridor. In the setting of clinical evaluation after previous endo-
nasal pituitary surgery, particular attention should be paid to
the extent of the septectomy defect and integrity of the naso-
septal flap pedicle.
Figure 1. A patient with extensive chronic rhinosinusitis of the maxillary and eth-
moid sinuses, nasal polyps and a left septal spur (arrow) in the pre-operative set-
ting for a pituitary adenoma resection.
Figure 2. A patient with a concha bullosa (star) on pre-operative evaluation for a
pituitary adenoma resection. Partial turbinectomy with excision of the concha
bullosa can be considered to provide adequate exposure.
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Intra-operative considerations
There are few intranasal anatomical structures that prohibit
endonasal skull base surgery, but structures along the endonasal
corridor may require resection or mobilization.23 Surgical access
can involve a range of procedures including, unilateral luxation
of the middle turbinate, complete bilateral ethmoidectomy, and
may require complementary procedures such as septectomy.23
Planned endonasal procedures are intended to develop a large
surgical corridor to the posterior nasal cavity that accommodates
four-hand surgery, while preserving sinonasal anatomy and func-
tion, maintaining ostia patency, minimizing crusting and pre-
venting scar formation.3,13,26 The use of careful endoscopic sinus
surgical techniques reduces sinonasal morbidity, including crust-
ing, scarring or osteogenesis following trauma, with comparable
or superior surgical results.27
Management of the turbinates
Turbinates are outpouchings from the lateral nasal wall that are
essential for humidification, filtration, and temperature regulation
of nasal airflow and serve as an important surgical landmark.
They also provide nasal resistance and contain sensory fibers
essential for the perception of nasal airflow, including olfactory
fibers in the superior region of the middle and superior turbi-
nates.28,29 Surgical manipulation of the turbinates is often
required to expand the endonasal corridor. For minimal obstruc-
tions, the inferior turbinate may be observed or lateralized to
expose the inferior nasal cavity. In rare instances where the infer-
ior turbinate poses a greater degree of obstruction, a partial tur-
binectomy may be considered.30 The middle turbinate can be
addressed through lateralization, partial turbinectomy (Figure 3),
or complete turbinectomy to maximize the space between the
turbinate and nasal septum.3,26 Sacrifice of the middle turbinate
may be indicated for turbinate dysfunction secondary to polypoid
degeneration, concha bullosa, or a paradoxical middle turbinate
contributing to nasal obstruction or sinus disease.29–31 However,
routine turbinectomy for surgical access to the paranasal sinuses
has remained controversial.29 Middle turbinectomies have not
been found to provide significant surgical exposure or freedom
as compared to middle turbinate lateralizations.32 However, post-
operative debridements are easier to perform after middle turbin-
ate resection. In 2001, the American Rhinologic Society released
a consensus statement that recommended surgeons avoid sacri-
fice of the middle turbinate without a satisfactory reason, and
consider conservative reduction of the inferior turbinate.30
Post-operative Lateralization of the middle turbinate is an
adverse sequelae of preservation of the middle turbinate with a
potential for scar formation and obstruction of the outflow tract
from the maxillary, ethmoid and frontal sinuses.33,34 The inci-
dence of middle turbinate lateralization is unclear but it is
reported in 10–40% of endoscopic skull base surgery cases.34
Medialization of the middle turbinate intraoperatively with a
transseptal suture or insertion of absorbable implants can reduce
synechiae formation and lateralization.33,35
Management of the nasal septum
The nasal septum is a midline bony-cartilaginous structure that
divides the nasal passages. Manipulation and resection of the
nasal septum may be required to provide additional exposure in
the transsphenoidal approach. However, surgeons should pre-
serve normal nasal septum when possible to reduce the risk of
structural compromise of the nose or septal perforation.14
Septoplasties for severe nasal septal deviation that obstructs the
endonasal corridor are required infrequently, reported in 1.8% of
cases.36 A dorsal and caudal septal segment of 1 cm, termed the
L-strut, must be maintained to ensure dorsal and tip support for
the nose.14 In order to establish binarial exposure of the sphen-
oid sinus, a posterior septectomy must be performed.32 A poster-
ior septectomy of 15mm provides surgical exposure equivalent to
the mean inter-opticocarotid recess. Additional septectomy
beyond 20mm does not provide significant additional surgical
exposure or freedom.32 While many surgeons removing the bony
septum entirely, it may be profligate in most cases.
Skull base reconstruction
The ideal technique for closure of the skull base defect that facili-
tates healing, reduces intracranial infection and prevents cerebro-
spinal fluid leaks remains controversial. At its inception, skull
base closure for endoscopic skull base surgery required recon-
struction in several planes, comprised of an inlay, dural and
onlay graft. However, as its popularity expanded, studies have
demonstrated favorable outcomes in watertight closure with sin-
gle layer closures.23 The materials used to reconstruct the skull
base must be carefully selected to reduce foreign body reactions
and associated intranasal irritation, inflammation and infection.
Dural defects can be reconstructed with allografts or autologous
material (fat, turbinate, nasal mucosa, conchal cartilage, tempor-
alis fascia, fascia lata).23
The use of a vascularized flap can be considered for dural
reconstruction particularly in the setting of high flow cerebro-
spinal fluid leak encountered intraoperatively.37 The nasoseptal
flap is an extension of concepts in surgery wherein pedicled vas-
cularized flaps are the gold standard for healing defects. A rota-
tional, vascularized flap based on the posterior septal artery, the
nasoseptal flap is unquestionably the workhorse for dural defect
closures in endoscopic skull base surgery.14,38,39 Nasoseptal flaps
are selected for skull base reconstruction in an estimated 25–50%
of cases.40
Nasoseptal flaps must be raised prior to exposing the sphen-
oid, in anticipation of a large defect or an unexpected cerebro-
spinal fluid leak. In such cases where a nasoseptal flap is not
raised, a “rescue” flap approach can be raised at the end of the
case, which consists of partially harvesting the most superior and
posterior aspect of the flap to protect its pedicle and provide
access to the sphenoid face during the approach. The rescue flap
also minimizes septum donor site morbidity.41 If one is not
inclined to harvest a flap initially, it is recommended that the
posterior septectomy be performed such that the vascular pedicle
of a potential flap is spared. Large skull base defects may be
reconstructed with the posterior pedicled inferior turbinate-naso-
septal flap, a large intranasal flap based on the posterior lateral
nasal artery.42 Resected turbinates can be also used for sellar
reconstruction at the end of surgery for small defects and may be
considered when the nasoseptal flap is unavailable due to
prior surgery.43
Packing following endonasal endoscopic skull base surgery
Surgeons are not obliged to use nasal packing or stents provided
there is no heavy bleeding or concern for structural compromise.
Packing may be inserted into the nasal cavity after surgery for
hemostasis, internal stabilization for the bony and cartilaginous
nasal structure and to prevent adhesions or scar formation.27,44
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There are an increasing number of products available for packing
and stenting of the nasal cavity but little guidance for recom-
mended materials, duration for packs to remain in place or when
placement is indicated.27 Nasal packs are nasal foreign bodies
that must be removed before inflammatory complications occur.
Materials should be easily identified from outside the nose after
surgery, and carefully documented and discussed with the
patient. The foreign bodies must be firmly secured and follow up
must be arranged for removal.27 Nasal packing may be removed
on the day of surgery or up to 3 days postoperatively.44
Post-operative considerations
Immediate post-operative period
The nature and duration of post-operative antibiotic therapy
remains unclear as several algorithms have been proposed in the
literature.45,46 Patients typically receive gram-positive cocci cover-
age for retained nasal foreign bodies, including nasal packing,
and to prevent intracranial infection.40 Post-operative meningitis
is estimated to occur in 0.7–4.5%% of endoscopic skull base
cases, increasing to 28.5–66.0% in cases with cerebrospinal fluid
leaks.40,47–50 Patients should remain on oral antibiotics while
nasal packing is in place. Nasal packing should be removed
within 48–72 hours of insertion. Nasal splints should be removed
2–3 weeks following nasoseptal flap harvest. A complete evalu-
ation of the nasal cavity should be performed at each interval.
Outpatient follow-up
Patient education and regular patient visits are key to ensuring
maximal sinonasal health in the post-operative period. Follow-up
should be coordinated between the neurosurgery and otolaryn-
gology teams to achieve adequate continuity of care. The timing
of follow-up is dependent on nasal packing post-operatively,
nasal irrigation, degree of nasal crusting, and extent and fre-
quency of debridement. Nasal crusting is the most common post-
operative symptoms following skull base surgery, with a median
time to absence of crusting of 101.0 days.51 Routine nasal saline
rinses are recommended to reduce accumulation of nasal debris
and facilitate healing (Figure 3). Nasal irrigations should be initi-
ated 72 h post-operatively, after nasal packing is removed, for
passive debridement of nasal crusting and discharge. Active
debridement can be initiated between post-operative day 7 and
14 in order to reduce accumulation of nasal debris. Frequency of
postoperative visits by otolaryngology is dictated by degree of
nasal crusting and frequency of nasal irrigations but should typ-
ically be continued on a monthly basis. Effective nasal irrigation
can decrease the necessity for in-office debridements. Patients
should continue nasal irrigation and routine debridement until
satisfactory healing is observed.
Complications
The popularity of the endonasal approach is credited to its
reduced morbidity and rapid recovery in comparison to the
transcranial approach. However, the endonasal approach presents
a unique set of morbidities associated with the endonasal corri-
dor, paranasal sinuses and nasoseptal flap reconstruction that
may still affect quality of life.52 The sinonasal outcome test
(SNOT)22 is a disease-specific validated questionnaire used to
quantify sinonasal function with a higher score indicating worse
outcome. An estimated 27% of patients score 4.0 or greater
indicating a severe problem relating to loss of smell or taste.
Interestingly, SNOT-22 scores are lower in patients who did not
have nasal septal flap reconstruction compared with those who
did. Overall, mean SNOT-22 scores progressively improve after 1
to 3 months following surgery, with the lowest SNOT-22 scores
observed after 6 to 12 months in over 75% of patients.52
Trauma to the nasal corridor and paranasal sinuses is associ-
ated with sinonasal morbidity, including sinusitis, synechia, anos-
mia, epistaxis, septal perforation, nasal congestion, internal nasal
valve failure and impaired mucociliary clearance.15,53–59
Postoperative rhinosinusitis following transsphenoidal resection
of pituitary tumors occurs in an up to 10% of patients and may
persist for an average of 2.9 years.40,60 Nasal synechia refers to
scar formation between the structures of the lateral nasal wall
and the septum or turbinates. The reported incidence of nasal
synechaie is 9–20% in endonasal skull base surgery.61 Post-opera-
tive epistaxis is a sequela of injury to the sphenopalatine artery.
The reported incidence of delayed post-operative epistaxis is
0.6–3.3%, presenting 13 weeks post-operatively.62 Conservative
management includes bedside nasal packing, balloon tamponad-
ing, or cauterization. Embolization of the sphenopalatine artery
or internal maxillary artery is recommended when bedside
maneuvers fail.62 Endonasal surgery may cause changes in nasal
volume and resistance leading to increased nasal airflow and
hypernasal speech. Hypernasality is a notable complaint in the
postoperative setting, particularly amongst patients over age 60.63
Septal perforations are an infrequent complication of transsphe-
noidal surgery, although its occurrence has been reported in the
literature.64 Careful dissection of the subperichondrial plane in
elevation of the nasoseptal flap and assurance of opposing, well-
vascularized, mucosal flaps after reconstruction of the septum is
critical for preventing septal perforations.
Olfactory dysfunction can be observed following endonasal
skull base surgery for several reasons and result in transient or
permanent disability. In the early post-operative period, obstruct-
ive nasal crusting can prevent odorants from stimulating sensory
fibers.59 Excessive mucosal sacrifice during an endonasal endo-
scopic approach may lead to destruction of the olfactory epithe-
lium on the turbinates and septal olfactory mucosa.65 Rotenberg
Figure 3. Favorable healing of the nasopharynx surgical corridor following trans-
sphenoidal approach to pituitary adenoma resection. Minimal crusting is seen
with adequate saline irrigation and routine debridements (star¼ remnant anter-
ior septum).
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et al.66 identified a significant decrease in olfactory outcomes fol-
lowing transsphenoidal surgery. Patients administered the
University of Pennsylvania Smell Identification Test (UPSIT)
reported a mean preoperative UPSIT value of 37.2 (normosmia),
and a mean postoperative UPSIT value of 30.8 (moderate hypo-
smia). The authors hypothesize that olfactory impairment results
from use of the nasoseptal flap and recommend judicious use of
the nasoseptal flap given the potential for permanent olfactory
changes. Patients should be counseled on the possibility of per-
manent post-operative olfactory changes.66 Preservation of the
upper nasal septum in elevation of the nasoseptal flap and resec-
tion of the nasal septum may reduce the risk of olfactory dys-
function in the post-operative setting.
Aggressive resection of the turbinates, an essential source of
respiratory resistance, can result in paradoxical nasal obstruction,
so-called empty-nose syndrome. Empty nose syndrome, a poorly
recognized but devastating complication of excessive intranasal
resections, is an iatrogenic disorder characterized as subjective
poor nasal breathing despite a patent nasal airway.67,68 A lack of
turbinate tissue creates an impaired sensation of nasal airflow
while the distal respiratory structures (that is, the pharynx and
lungs) and manometric flow studies will continue to indicate a
fully patent airway.67 This conflicting information can lead
patients to report a sensation of suffocating or constant dyspnea,
and may result in a preoccupation with nasal breathing, poor
concentration (aprosexia nasalis), chronic fatigue and depression.
Furthermore, patients may suffer from hyposmia, sleep-disor-
dered breathing, and squamous metaplasia of the remaining nasal
mucosa due to excess exposure to dry and cold air.67 Empty nose
syndrome is a rare, albeit possible, complication following endo-
scopic skull base surgery, although high quality evidence on this
topic is lacking.69–71 Management of empty nose syndrome can
be challenging. Primary interventions should focus on avoidance
of superfluous resection of intranasal structures, a consideration
to which surgeons should be particularly conscious of in the set-
ting of endonasal skull base surgery where normal nasal struc-
tures are removed. Treatment goals in patients with empty nose
syndrome should focus on open dialogue with patients regarding
their symptoms, moisturization and reconstruction of nasal struc-
tures.67 A significant improvement in SNOT-20 and 25 scores
following surgical intervention are reported in the majority of
patients. However, clinical response varies among patients with
up to 21% reporting only marginal improvement.68
Pediatric perioperative considerations
Endoscopic endonasal skull base surgery has proved to be safe
and effective for the management of pediatric pituitary adeno-
mas.72,73 However, there is limited evidence to guide periopera-
tive treatment strategies for pediatric patients. A transsphenoidal
approach to pediatric skull base lesions requires consideration of
age-related differences in endonasal skull base anatomy. Access
to the skull base involves navigation through the narrow nasal
aperture and entry into an incompletely pneumatized sphenoid
sinus. Care should be given to the anatomic restrictions of the
nasal passages of pediatric patients, as the nasal pyriform apera-
ture width is significantly smaller in children under age 7 as
compared to adults.74 Sphenoid sinus pneumatization occurs
from age 2 years to age 14 years.75 The anterior inferior margin
of the sphenoid sinus pneumatizes earlier than the anterior
superior margin.74 This pneumatization pattern confirms that the
medial, anteroinferior margin of the sphenoid bone is the safest
entry point for a trans-sphenoidal approach.74 Recent studies
have shown that reconstruction of skull base defects with a naso-
septal flap is a reliable option in patients over 14 years of age, as
these children have adult-sized septums capable of full cover-
age.76 Use of the nasoseptal flap in patients age 10–13 years
requires careful consideration of individual facial analysis and
skull base and septal measurements of preoperative imaging.76
Post-operative debridements can be challenging in younger
patients and may require scheduled operative endonasal surgery.
Conclusions
Several anatomic and pathologic features must be considered in
the endonasal approach to the skull base. We provide a series of
recommendations for management of the paranasal sinuses and
endonasal corridor to optimize surgical outcomes and patient
quality of life (Table 1). Further studies are needed to determine
standardized perioperative measures to be taken in endoscopic
skull base surgery for pituitary diseases. In order to further
advance transsphenoidal management of pituitary diseases,
Table 1. Summary of perioperative management of the paranasal and endonasal corridor in endoscopic transsphenoidal surgery.
Pre-operative considerations
Complete history and physical examination including nasal endoscopy
Patients with acute rhinosinusitis and fungal paranasal sinus disease should undergo planned staged procedures.
Patients with chronic rhinosinusitis may be treated with concurrent functional endoscopic sinus surgery and endonasal skull base surgery
Surgeons may counsel patients around potential post-operative sinonasal morbidity, including nasal crusting, nasal discharge, sinusitis, olfactory dysfunction and
hypernasality.
Perioperative steroids can be considered for chronic paranasal sinus disease with nasal polyposis
Neuroimaging investigations should be performed to identify anatomic variants, establish nasal structure and delineate skull base pathology
Intra-operative considerations
Establish a large endonasal corridor but avoid excess resection of intranasal structures.
Turbinate lateralization should be considered when a sufficient endonasal corridor can be established. Partial and complete turbinectomies should be used
judiciously.
Anterior septoplasty is required for caudal septal deviations that obstruct the endonasal corridor.
A posterior septectomy of 15mm is sufficient to provide surgical exposure equivalent to the mean inter-opticocarotid recess.
Preserved middle turbinate should be medialized with a transseptal suture or absorbable implant in the medial meatus.
A nasoseptal flap may be considered for large skull base defects and in the setting of high-flow cerebrospinal fluid leaks.
Post-operative considerations
A minimum of 48 h of antibiotic gram-positive coverage or the duration of nasal packing
Nasal packing removal within 48–72 h and nasal splint removal after 2–3 weeks
Nasal irrigations should be initiated after 72 h post-operatively
In-office debridements begin 7–14 days following surgery. The frequency of debridements are dependent on the efficacy of nasal irrigations.
Routine monthly visits to evaluate patients for symptoms of olfactory dysfunction, sinusitis, empty nose syndrome and hypernasaity, and evidence of nasal
crusting, discharge, synechiae, middle turbinate lateralization and septal perforation should be performed.
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standardized algorithms and outcome metrics are needed to
ensure quality assurance. The implementation of a standardized
treatment algorithms, as proposed in this manuscript, will
improve surgical and patient-reported outcomes, and increase
comparability across research studies.
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